This result linking with the observed effects on glioma cells by C18H17NO6 and its combination with Scutellarin suggested that the underlying mechanism of these drugs might be upregulation of FAF1, which might be a valid therapeutic target and provide a novel mechanism by which to treat glioma. Here, FAF1 is linked to central nervous system cancer.